Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...

A new pancreatic cancer treatment targeting the KRAS gene mutation represents a major breakthrough, offering the first ...

New KRAS-targeting drug for metastatic pancreatic cancer nearly doubles second-line survival; expert explains impact, side ...

The drug will be used in conjunction with other treatments that yield results.

Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune ...

Russ Reed finally got his cancer drug, but others mired in red tape. “There are a lot of people who are going to die ...

A newly identified inflammatory signaling target may help weaken the protective environment surrounding pancreatic tumors and make existing treatments more effective.

Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to treat. One major reason is that pancreatic tumors often create a "cold" tumor ...

A new drug is doubling survival time for pancreatic cancer patients. Daraxonrasib, the drug being taken by former Sen. Ben ...

Background New-onset diabetes (NOD) increases the risk of pancreatic cancer. Previous studies have mainly focused on the presence or absence of diabetes, with limited attention to NOD severity at ...

The fight against deadly pancreatic cancer took a positive turn this spring with a study finding a new drug can help patients ...